| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191311 | Annals of Allergy, Asthma & Immunology | 2013 | 4 Pages |
Abstract
More studies are needed to better clarify the optimal dose, IgG trough level, or IgG steady-state level necessary to reduce infection and optimize treatment for patients with PIDD treated with IVIG or SCIG.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mark MD,